A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Clinical trial NCT05787587 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05787587
Sponsor: IDEAYA Biosciences
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors Breast Cancer Ovarian Cancer Prostate Cancer Endometrial Cancer Colorectal Cancer Head and Neck Cancers Extensive Stage Small Cell Lung Cancer (ES-SCLC)NSCLC

Start date: 2023-04-18
Primary completion: 2026-10-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.